Madrigal Pharmaceuticals (MDGL) Stock Forecast & Price Target
Score
Madrigal Pharmaceuticals, Inc. price target
| MDGL | |
|---|---|
| Low | $542.00 |
| Average | $684.80 |
| High | $962.00 |
| Upside vs current price | +60.2% |
The average target of $684.80 is +60.2% versus the current MDGL price of $427.39.
Madrigal Pharmaceuticals, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 3 |
| Buy | 15 |
| Hold | 1 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
19 analysts cover MDGL.
Madrigal Pharmaceuticals, Inc. EPS and revenue estimates
The estimate table for the Madrigal Pharmaceuticals, Inc. keeps 2026 EPS $-2.75, 2027 EPS $6.82, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $-2.75 | $1.57B |
| 2027 | $6.82 | $2.17B |
Is Madrigal Pharmaceuticals, Inc. a buy or sell?
Of the 19 analysts covering Madrigal Pharmaceuticals, Inc., 18 rate it a buy (3 strong buy and 15 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The MDGL consensus label is Buy, beside 18 buy-side ratings and 0 sell-side ratings.
The average target of $684.80 implies +60.2% versus the current price of $427.39.
the Madrigal Pharmaceuticals, Inc. closes with 18 buy-side ratings and 0 on the sell side. The headcount is Buy.
Reading the Madrigal Pharmaceuticals, Inc. forecast
Analysts are far apart on MDGL. The published low is $542.00, the average is $684.80, and the high is $962.00.
From today's $427.39 print, the MDGL average target is +60.2% away.
Most of the MDGL coverage agrees: 18 of 19 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.
MDGL has both upgrades (1) and downgrades (0) in the recent window.
The MDGL average target is little changed, $702.50 over the last month and $703.00 over the last quarter.
Coverage of MDGL is broad at 19 analysts, and the average is a crowd rather than a single desk.
Madrigal Pharmaceuticals, Inc. forecast questions
What is the MDGL price target?
The published range for MDGL is $542.00 to $962.00, with an average of $684.80. That average is +60.2% versus the current price of $427.39.
Is Madrigal Pharmaceuticals, Inc. a buy or sell?
Of the 19 analysts covering Madrigal Pharmaceuticals, Inc., 18 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, which for MDGL is 18 on the buy side, 1 at hold, and 0 on the sell side.
What is the EPS estimate for Madrigal Pharmaceuticals, Inc.?
Analyst EPS estimates for Madrigal Pharmaceuticals, Inc.: 2026 $-2.75, 2027 $6.82.
What is the revenue estimate for Madrigal Pharmaceuticals, Inc.?
Analyst revenue estimates for Madrigal Pharmaceuticals, Inc.: 2026 $1.57B, 2027 $2.17B.
How many analysts cover MDGL?
19 analysts cover MDGL. Their consensus on MDGL is Buy, across those 19.